cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Growth Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aebischer, CC; Keller, BM; Kraemer, R; Schöni, MH | 1 |
1 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and Growth Disorders
Article | Year |
---|---|
Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
Topics: Adolescent; Analysis of Variance; Body Height; Body Mass Index; Body Weight; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Genotype; Growth Disorders; Homozygote; Hospitals, Pediatric; Humans; Linear Models; Longitudinal Studies; Male; Maximal Midexpiratory Flow Rate; Mutation; Peptide Fragments; Retrospective Studies; Switzerland; Vital Capacity | 2003 |